Africa Medicines for Africa’s Lenias Hwenda reflects on Moderna’s recent decision not to go ahead with plans for a vaccine manufacturing facility in Kenya, and why local production remains crucial to building Africa’s healthcare autonomy. In a turn of events that is both disappointing yet somehow not surprising, Moderna recently…
Kenya Medicines for Africa’s Lenias Hwenda examines the significance of Moderna’s USD 500 million investment into African manufacturing, other agreements in place to boost manufacturing capacity on the continent, and why a more equally distributed global pharmaceutical manufacturing network is in the interest of the entire planet. Many Africans welcome…
See our Cookie Privacy Policy Here